Related Experiment Video
Updated: Mar 3, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
The Middle Molecule Hypothesis Revisited. Should Short, Three Times Weekly Hemodialysis Be Abandoned?
Bernard Charra1, Belding H Scribner2, Zbylut J Twardowski3
1Centre de rein de Tassin, Centre de rein artificiel, Tassin, France.
Abstract:
When the middle molecule (MM) hypothesis was formulated in 1975, no MM had yet been identified as a uremic toxin. Meanwhile, the birth and implementation of the Kt/Vurea concept gained wide acceptance and has remained the world standard for assessing dialysis adequacy. However, over the past 20 years, accumulating evidence has made it clear that MM's are important uremic toxins, and that the dose of dialysis based on removal of small molecular substances does not protect against excessive hemodialysis mortality, morbidity, or the presence of uremic signs and symptoms. These poor results are, in one way or another, linked to the accumulation of MM's and other substances behaving like MM's, such as phosphate. Dialysis schedules yielding the best clinical results, such as longer dialysis and more frequent dialysis, favor increased removal of middle molecular substances. The observation that short daily dialysis is giving results similar to long nocturnal quotidian dialysis supports early observations that the volume from which middle molecular substances are extracted mainly by hemodialysis is small (about as large as the extracellular volume), and that transfer of MM's from cells to extracellular fluid is very slow. This behavior of MM's is markedly different from that of small molecular substances, which are more rapidly transferred from intracellular to extracellular compartments and are more readily extracted from total body water during hemodialysis. In order to achieve even minimum adequate dialysis, it is now scientifically validated that toxic MM's must be removed in larger amounts than currently attained. This can only be accomplished by long dialysis sessions with a 3-times per week schedule or more frequent dialyses. Five hours 3 times per week represents the absolute minimum treatment. Dialy sis 6 to 7 times per week is the ideal schedule for patients who are willing to commit the time and effort in exchange for maximum well-being and long survival.
Insights
Middle molecules (MMs) are key uremic toxins. Current dialysis methods focusing on small molecules are insufficient, leading to poor patient outcomes. Longer, more frequent dialysis is essential for effective MM removal and improved survival.
Area of Science:
- Nephrology
- Uremic Toxin Research
- Dialysis Efficacy
Background:
- The middle molecule (MM) hypothesis, proposed in 1975, identified MMs as potential uremic toxins before their specific identification.
- The Kt/Vurea concept became the standard for dialysis adequacy, focusing on small molecule removal.
- Accumulating evidence over 20 years links MM accumulation to hemodialysis mortality, morbidity, and uremic symptoms.
Purpose of the Study:
- To re-evaluate dialysis adequacy beyond small molecule clearance.
- To highlight the critical role of middle molecules (MMs) in uremic toxicity.
- To advocate for dialysis strategies that enhance MM removal.
Main Methods:
- Review of accumulating evidence on MM toxicity and dialysis outcomes.
- Comparison of MM removal characteristics versus small molecule removal during hemodialysis.
- Analysis of clinical results from different dialysis schedules (frequency and duration).
Main Results:
- MMs, including phosphate, are significant contributors to uremic toxicity and poor dialysis outcomes.
- Standard dialysis based on small molecule removal (Kt/Vurea) does not adequately address MM accumulation.
- Longer and more frequent dialysis sessions (e.g., daily or 6-7 times/week) significantly improve MM removal and clinical results.
- MMs are slowly transferred from intracellular to extracellular fluid, requiring extended dialysis for efficient removal.
Conclusions:
- Effective management of uremic toxicity necessitates substantial removal of middle molecules.
- Current dialysis standards are inadequate due to insufficient MM clearance.
- Achieving adequate dialysis requires longer sessions (minimum 5 hours, 3 times/week) or more frequent schedules (6-7 times/week) for optimal patient well-being and survival.
Related Concept Videos
Hemodialysis III: Nursing Management
Hemodialysis II: Procedure and Complications
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Hemodialysis I: Introduction
Dialysis
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...

